Search results for "Highlights"
Sickle cell trait affects HbA1c's accuracy as a measure of glycemia, study finds
Mean HbA1c was 5.7% in the African-American participants with sickle cell trait and 6.0% in those without, despite similar mean fasting and two-hour glucose values.
https://diabetes.acponline.org/archives/2017/02/10/2.htm
10 Feb 2017
Continuous glucose monitoring associated with lower HbA1c in type 1 diabetes treated with insulin injection
An editorial accompanying the two trials of continuous glucose monitoring stressed that the physicians involved had extensive experience with the technology and noted that the necessary changes in lifestyle and insulin dosing can be variable and complicated.
https://diabetes.acponline.org/archives/2017/02/10/3.htm
10 Feb 2017
Position statement on diabetic neuropathy urges early recognition, appropriate management
The American Diabetes Association offered advice on prevention, screening, and treatment of diabetic peripheral neuropathies and cardiovascular autonomic neuropathies.
https://diabetes.acponline.org/archives/2017/02/10/1.htm
10 Feb 2017
Higher prevalence of complications in young adults diagnosed with type 2 vs. type 1 diabetes
Compared to those with type 1 diabetes, participants with type 2 had a significantly higher age-adjusted prevalence of diabetic kidney disease, retinopathy, peripheral, arterial stiffness, and hypertension by age 21.
https://diabetes.acponline.org/archives/2017/03/10/3.htm
10 Mar 2017
Dapagliflozin associated with lower risk for all-cause mortality in type 2 diabetes regardless of CVD risk, study finds
The population-based retrospective cohort study included 22,124 type 2 diabetes patients from a British national primary care database, 4,444 of whom had taken dapagliflozin.
https://diabetes.acponline.org/archives/2017/03/10/2.htm
10 Mar 2017
ADA position statement updates recommendations for diabetic retinopathy
The position statement, an update of one from 2002, outlines the stages of diabetic retinopathy and highlights recommendations on optimal blood glycemic control and lowering blood pressure.
https://diabetes.acponline.org/archives/2017/03/10/1.htm
10 Mar 2017
Insulin pump didn't improve glycemic control compared to training on injections
British patients with type 1 diabetes were enrolled in group training courses that taught flexible intensive insulin treatment and then randomized to an insulin pump or multiple daily injections and followed for two years.
https://diabetes.acponline.org/archives/2017/04/14/3.htm
14 Apr 2017
Spotlight on diabetes incidence and complications
Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.
https://diabetes.acponline.org/archives/2017/04/14/5.htm
14 Apr 2017
Approved drugs for diabetic neuropathy better than placebo, review finds
In addition to approved drugs duloxetine, pregabalin, and tapentadol, some benefits were found with venlafaxine, oxcarbazepine, tricyclic antidepressants, tramadol, and botulinum toxin.
https://diabetes.acponline.org/archives/2017/04/14/2.htm
14 Apr 2017
Newer glucose-lowering drugs associated with lower mortality risk than insulin
Researchers compared Swedish patients with type 2 diabetes who were new users of dipeptidyl peptidase-4 inhibitors or sodium-glucose cotransporter-2 inhibitors with patients initiating insulin.
https://diabetes.acponline.org/archives/2017/04/14/1.htm
14 Apr 2017